Crescent Biopharma, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: CBIO
Crescent Biopharma, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its shares trade on Nasdaq under the ticker CBIO. It has reported private securities offerings to the US SEC, most recently $39 million sold in a notice filed in 2010.
Crescent Biopharma at a glance
What does Crescent Biopharma do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $39 million sold (2010).
Frequently asked questions about Crescent Biopharma
Where is Crescent Biopharma headquartered?
Crescent Biopharma, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Crescent Biopharma do?
Crescent Biopharma, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Crescent Biopharma a public company?
Yes. Crescent Biopharma, Inc. trades on Nasdaq under the ticker CBIO.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.